“Do you know a company called [name redacted]?” the colleague asked on the phone. “Yes,” I replied. I had been familiar with the firm and its business model for several years. It is a relatively small outfit based in Shanghai, not widely known and not particularly relevant to private equity. So what about it?
"Well," the colleague continued, "they want to raise a renminbi fund to invest in SMEs." I wasn't particularly surprised - it seems that everyone in China has sought to leverage slivers of proprietary...
China healthcare-focused GP C-Bridge Capital and Tasly Holding, a traditional Chinese medicine business, have agreed to invest $150 million in a newly-created entity formed through the merger of two local pharmaceutical companies.
Kuaishou, a Chinese live-streaming video app backed by VC investors and search engine Baidu, has raised $350 million in a new round of funding led by Tencent Holdings.
The Riverside Company has completed its second deal in Malaysia as Drex-Chem Malaysia (now known as DCM Asia), the chemicals distributor it bought in 2014, acquired Erapoly Marketing.
The Carlyle Group has led an investment of more than $100 million in Indian delivery e-commerce logistics service Delhivery. Existing backer Tiger Global Management also took part in the funding round.